
He co-founded Albany Molecular Research in 1991, when asking companies to share their chemistry was a difficult proposition. The company became Curia; his other lasting investments put chemists back in the classroom.

Before Olivier Roux sold manufacturing partnerships, he validated methods, managed reference standards and wrestled with process details. His career is a case study in how technical depth becomes commercial judgment.